5-Phenoxytryptamine
chemical compound
5-Phenoxytryptamine (5-PhO-T), also known as OVT2 or Otava 3736689, is a psychedelic drug of the tryptamine family related to 5-methoxytryptamine (5-MT; 5-MeO-T). It is the derivative of tryptamine and 5-methoxytryptamine in which there is a phenoxy group at the 5 position. The drug acts as a biased agonist of the serotonin 5-HT2A receptor, favoring Gαi signaling over Gαq and β-arrestin1 signaling, though not favoring Gαq signaling over β-arrestin2 signaling. Its affinity (Ki) for the serotonin 5-HT2A receptor is 57.5 nM and its activational potency at this receptor ranges from 0.28 nM to 15,800 nM and efficacy ranges from 30% to 91% depending on the downstream signaling pathway. OTV2, given via intracerebroventricular injection, produces the head-twitch response, a behavioral proxy of psychedelic effects, in rodents. In addition, it produces long-term memory deficits that are dependent on serotonin 5-HT2A receptor activation in rodents. The drug was first described in the scientific literature by Elk Kossatz and colleagues in 2024.
Begin with the source’s own compact description: “5-Phenoxytryptamine” is chemical compound. The dossier treats that line as a proposition to test through 5-Phenoxytryptamine, chemical and compound, not as a finished interpretation.
Why this record matters
The phrase “chemical compound” supplies a clear boundary for inquiry. It also exposes the unanswered questions: who defined that boundary, when it became stable and which sources sit outside it.
The date and method of observation matter as much as the stated conclusion, especially where classification or consensus has changed. The source revision retrieved here is dated Aug 11, 2026. The linked authority identifier is Q83056296. None of the 0 selected statements returned an explicit reference. The first chronological checks are 2024.
Current terminology should not be projected backward without checking the classification used when the underlying evidence was created. The lead is largely declarative, so disagreement and counter-evidence require a deliberate search beyond the opening account. Authority statements aid reconciliation but still require their own references, qualifiers and ranks to be checked.
How to read it
Check terminology, classification and the date of the cited evidence. Scientific names and technical consensus can change while older records retain historical value.
- Current terminology
- Classification context
- Finding cited technical literature
Primary datasets, specimen catalogues, standards bodies and the most recent peer-reviewed literature.
Three-step research path
- Establish the record: confirm the title “5-Phenoxytryptamine”, its source revision and the description used here.
- Expand the search: follow 5-Phenoxytryptamine primary sources, 5-Phenoxytryptamine archive and 5-Phenoxytryptamine research across catalogues and specialist indexes.
- Test the account: compare the strongest cited source with the responsible institution’s current record and note any disagreement.
Questions for further research
- Which source most directly establishes the central claim about “5-Phenoxytryptamine”?
- Has classification or technical consensus changed since the cited source?
- Is the terminology current, historical or disputed?
Search terms from this dossier
This entry incorporates text from “5-Phenoxytryptamine” on English Wikipedia. Contributors are listed in the page history. Text is available under the Creative Commons Attribution-ShareAlike 4.0 License. Selected authority identifiers and statements are retrieved from Wikidata under CC0; their references and qualifiers remain part of the verification path.